A malaria drug that President Donald Trump said could possibly treat coronavirus disease (COVID-19) is already in short supply, according to ASHP. However, Teva said it will donate millions of tablets to US hospitals.
What new gaps will pharmacists need to fill?
The FDA previously approved sofosbuvir and velpatasvir to treat HCV in adults.
It’s my hope that 2020 is a profession changing year, starting with the schools of pharmacy.
Genentech is launching a phase 3 clinical trial evaluating tocilizumab (Actemra) plus standard of care for use in hospitalized adult patients with severe COVID-19 pneumonia.
Perspectives from pharmacy associations in the states hardest hit with the COVID-19 outbreak.
A CDC analysis of preliminary data suggests that COVID-19 complications can occur in adults of any age.
A study identified significant similarities between SARS-CoV and SARS-CoV-2.
Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.
We asked pharmacists from various settings around the country: “Why did you become a pharmacist, and what keeps you motivated?"